Vanguard Global Advisers’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$735K Buy
55,502
+26,203
+89% +$331K ﹤0.01% 1905
2026
Q2
$324K Hold
29,299
– – ﹤0.01% 2296
2026
Q1
$224K Buy
+29,299
New +$224K ﹤0.01% 2384

Other funds holding REPL

Vanguard Global Advisers's REPL Position: Q3 2026 in Review

Vanguard Global Advisers increased its Replimune Group (REPL) stake by 89% in Q3 2026, buying an estimated $331K and bringing the position to 55,502 shares worth $735K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

Vanguard Global Advisers first reported a position in REPL in Q1 2026 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold REPL as of Q3 2026.

  • Vanguard Global Advisers held 55,502 shares of Replimune Group worth $735K as of Q3 2026.
  • Vanguard Global Advisers bought 26,203 Replimune Group shares in Q3 2026, an estimated $331K.
  • Replimune Group made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1905 holding.
  • Vanguard Global Advisers first reported a position in Replimune Group in Q1 2026 and has held it in 3 quarters since.
  • 209 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.